Search results for “Leukotriene Receptor Antagonists” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 323 patents, we discovered top 70 key players by total patent application. AstraZeneca Pharmaceutical Co., Ltd., MEDA Pharma GmbH & Co. KG, Intelgenx Corp. are dominant in this area. They take 34.06% of the total patent filing.
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 51
MEDA Pharma GmbH & Co. KG
Hessen, Germany
Patent: 33
Intelgenx Corp.
Canada
Patent: 26
Ono Pharmaceutical Co., Ltd.
Osaka-fu, Japan
Patent: 19
Elan Pharma International Ltd.
California, United States
Patent: 12
Verona Pharma Plc
United Kingdom
Patent: 11
Epigenesis Pharmaceuticals LLC
New Jersey, United States
Patent: 10
Omeros Corp.
Washington, United States
Patent: 8
Merck & Co., Inc.
New Jersey, United States
Patent: 7
AstraZeneca PLC
Cambridgeshire, United Kingdom
Patent: 7
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 1 patents, we discovered top 1 start-ups by total patent application.
Intarcia Therapeutics, Inc.
California, United States
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 58 patents applied in the last 5 years. We discover 14 most active companies in this area. The fast-growing Intelgenx Corp., Usun Bio, Verona Pharma Plc take 37.93% of patent filing during this period.
Intelgenx Corp.
Canada
Patent: 18
Usun Bio
Jiangsu Sheng, China
Patent: 2
Verona Pharma Plc
United Kingdom
Patent: 2
Zhongshan Hospital Fudan University
Shanghai Shi, China
Patent: 1
Venturepharma, Inc.
Beijing Shi, China
Patent: 1
Guangdong Motai Tongchuang Pharmaceutical Technology Co., Ltd.
Guangdong Sheng, China
Patent: 1
BioInspire Technologies, Inc.
California, United States
Patent: 1
Vanderbilt University
Tennessee, United States
Patent: 1
Afimmune Ltd.
DUBLIN, Ireland
Patent: 1
Syri Ltd.
Quebec, Canada
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 58 patents in last 5 years, we discover 10 new entrants. Usun Bio, Zhongshan Hospital Fudan University, Venturepharma, Inc. are the most active new entrants in this area.
Usun Bio
Jiangsu Sheng, China
Patent: 2
Zhongshan Hospital Fudan University
Shanghai Shi, China
Patent: 1
Venturepharma, Inc.
Beijing Shi, China
Patent: 1
EnliTISA (Shanghai) Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 1
BioInspire Technologies, Inc.
California, United States
Patent: 1
Vanderbilt University
Tennessee, United States
Patent: 1
Afimmune Ltd.
DUBLIN, Ireland
Patent: 1
Syri Ltd.
Quebec, Canada
Patent: 1
Bahçesehir Universitesi
Turkey
Patent: 1
Ulsan National Institute of Science & Technology
South Korea
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 27 patents, we discovered top 9 universities and scientific research institutions by total patent application. University of East London, Vanderbilt University, Washington University in St. Louis are dominant in this area. They take 22.22% of the total patent filing.
University of East London
United Kingdom
Patent: 4
Vanderbilt University
Tennessee, United States
Patent: 1
Washington University in St. Louis
Missouri, United States
Patent: 1
Universidade Federal de Minas Gerais
Minas Gerais, Brazil
Patent: 1
Pontifícia Universidade Católica de Minas Gerais
Minas Gerais, Brazil
Patent: 1
Yamaguchi University
Yamaguchi-ken, Japan
Patent: 1
Ulsan National Institute of Science & Technology
South Korea
Patent: 1
University of Toledo
undefined undefined
Patent: 1
Bahçesehir Universitesi
Turkey
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: